Please wait while we load the price list

Business Wire - Research and Markets: Analyze Dr Reddy’s - the Second Largest Pharmaceutical Manufacturer in India

November 21st, 2008

DUBLIN, Ireland — Research and Markets (http://www.researchandmarkets.com/reports/c57493 ) has announced the addition of the Espicom Business Intelligence Ltd report: Dr Reddy Generics Company Intelligence Report to their offering.
Our generic…

Business Wire - Verispan Reports: Prescription Samples for Seniors Falling in 2006

November 18th, 2008

YARDLEY, Pa. — The number of prescription samples given at doctors’ offices to patients 65 and older dropped during the first 7 months of 2006 compared to the same time period last year. Cholesterol reducers and diabetes medications experienced the greatest declines in samples issued among the top 10 therapeutic categories for seniors, falling 6% and 2%, respectively.
At the same time, the gap continued to widen between generi…

Journal of Family Practice - Does PCI added to drug therapy improve outcomes in stable CAD?

November 17th, 2008

* Clinical question
Do percutaneous coronary interventions (PCIs) improve outcomes when added to optimal medical therapy for patients with stable coronary disease?
* Bottom line
No. Optimal medical therapy–treatment with a statin, an antiplatelet agent, an anti-anginal medication, and an angiotensin-conver…

OB/GYN News - Bisphosphonate regimen options may improve compliance

November 13th, 2008

NEW YORK — Generic products account for six spots among the top 10 ranking of total prescription volume in the retail channel, according to NDCHealth Corp. In fact, the No. 1 product overall in terms of dispensed prescription count in 2004 was hydrocodone w/APAP, a gener…

Dermatology Nursing - What’s your assessment?(Clinical Skills)

November 6th, 2008

ANTIHYPERTENSIVE DRUGS
Patients taking angiotensin-converting enzyme (ACE) inhibitors such as lisinopril (Zestril) or angiotensin-receptor blockers such as irbesartan (Avapro) for hypertension and other cardiovascular conditions should be ca…

Journal of Nuclear Medicine, The - PET and Renovascular Disease

November 3rd, 2008

In an article e-published on January 2 ahead of print in Hypertension, Xia et al. from the Johns Hopkins Medical Institutions (Baltimore, MD) and the Mayo Clinic College of Medicine (Rochester, MN) reported on in vivo PET imaging and in vitro quantitative autoradiography of the angiotensin II subtype 1 receptor (AT1R) in a swine model of renovascular hypertension.

Related Results

Journal of Drugs in Dermatology - Lisinopril-induced erythroderma in an 85-year-old male

October 27th, 2008

Abstract
An 85-year-old male presented with a case of erythroderma secondary to lisinopril ingestion without a previous history of skin disease. While ACE inhibitors have been shown to elicit psoriatic erythroderma in previous cases, to our knowledge this is the first case report of iatrogenic …

Business Wire - Verispan Reports: Generics Shake Up Cardiovascular Market

October 24th, 2008

Business Editors/Health & Medical Writers
NEWTOWN, Pa.–(BUSINESS WIRE)–Jan. 23, 2003
After only 7 months of availability, lisinopril, a generic version of the popular ACE inhibitors Prinivil and Zestril, has already significantly affected the cardiovascular market.
Since its launch in June 2002, lisinopril has gained acceptance on 97% of managed care formularies, according to Verispan’s Fall 2002 Managed Care Formulary Drug Audit. Lisinopril is largely replacing Prinivil a…

Southern Medical Journal - Antinuclear Antibody–Negative, Drug-Induced Lupus Caused by Lisinopril.

October 18th, 2008

ABSTRACT: The clinical symptoms of drug-induced lupus (DIL) are similar to those of idiopathic systemic lupus erythematosus. The literature indicates that in patients with DIL, sera generally contain antinuclear antibodi…

Market Wire - Medicure Announces Presentation of Phase II Matched Results at Cardiovascular Conference

October 13th, 2008

Medicure Inc. (TSX: MPH)(AMEX: MCU), a cardiovascular-focused biopharmaceutical company, today announced that the positive results from the Phase II MATCHED study, which evaluated the combination of MC-1 and lisinopril in pa…